A Quick Look at Today's Ratings for Bristol-Myers Squibb(BMY.US), With a Forecast Between $37 to $60
Daily short sale tracking: Ambev SA's short volume increased by 4 million, with a short sale ratio of 10%
Ambev SA(ABEV.US) ranked top of the list had the largest change in short volume (4.72 million shares), and the short volume ratio of Carnival(CUK.US) reached 39.75%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
US stocks close | US PCE inflation cools down, S&P Nasdaq falls but Dow hits new high; China concept index surges 24% for the whole week, jd.com hits fourteen-month high.
US PCE inflation cooling solidifies the confidence of the Fed in rate cuts, but US stocks fell in the afternoon, with nvidia dropping nearly 4% at one point. China's stimulus policies drove the Chinese concept index up by 4%, nio inc rose by nearly 13%, pan-European stock indexes and German stocks hit new highs for two consecutive days, luxury goods stocks rose again. The Dow, S&P, and Nasdaq have all risen for three consecutive weeks, with two China-focused ETFs achieving the best weekly gains in history.
Express News | The Food and Drug Administration (FDA) of the USA has approved Bristol-Myers Squibb's Cobenfy (xanomeline).
J&J Releases Encouraging Data on Talvey Combination Therapies
Bristol-Myers Squibb Options Spot-On: On September 27th, 99,897 Contracts Were Traded, With 833.89K Open Interest
On September 27th ET, $Bristol-Myers Squibb(BMY.US)$ had active options trading, with a total trading volume of 99,897 options for the day, of which put options accounted for 23.47% of the total